Kohei Tatsumi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kohei Tatsumi has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
Midori Shima
Medicinal Biology of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan
6 shared publicationsAsuka Sakata
Medicinal Biology of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan
4 shared publicationsChihiro Hosoda
Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Nara 634-8521, Japan
4 shared publicationsYu Onodera
Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Nara 634-8521, Japan
4 shared publicationsSeiji Mitani
Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan
3 shared publications- Seiji Mitani
Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Nara 634-8521, Japan
3 shared publications
Latest Publications
- Open Access
- 8 July 2025
- Published by Wiley in FASEB BioAdvances
- Vol. 7 (7)
Prothrombotic Biomarkers Are Not Altered by Wood Smoke: A Pilot Controlled Exposure Study
Inhalation of wood smoke (WS) has been associated with increased risk of cardiovascular events, including heart attacks and strokes, both of which are caused in part by the thrombotic occlusion of blood vessels. To characterize the effects of WS on levels of established, circulating prothrombotic biomarkers, healthy human subjects at rest were exposed to WS (500 μg/m 3 ) or filtered air for 2 h. Plasma samples were then used to assess markers of endogenous procoagulant activity: cellular activation (tissue factor‐positive extracellular vesicles, TF + EVs), thrombin‐antithrombin complexes (TAT), fibrin formation/breakdown (D‐dimer), and thrombin generation potential. No significant differences in TF + EVs, TATs, D‐dimer, or thrombin generation parameters were detected between WS‐ or filtered air‐exposed individuals. Although females had significantly higher TATs and D‐dimers, and slightly but non‐significantly shorter thrombin generation lag times than males, there were no significant differences between WS‐ or air‐exposed males or females in any measurements. These data suggest that acute WS exposure does not increase prothrombotic biomarkers in plasma.
- 8 July 2025
- Published by Wiley in FASEB BioAdvances
- Vol. 7 (7)
Open AccessProthrombotic Biomarkers Are Not Altered by Wood Smoke: A Pilot Controlled Exposure Study
Inhalation of wood smoke (WS) has been associated with increased risk of cardiovascular events, including heart attacks and strokes, both of which are caused in part by the thrombotic occlusion of blood vessels. To characterize the effects of WS on levels of established, circulating prothrombotic biomarkers, healthy human subjects at rest were exposed to WS (500 μg/m 3 ) or filtered air for 2 h. Plasma samples were then used to assess markers of endogenous procoagulant activity: cellular activation (tissue factor‐positive extracellular vesicles, TF + EVs), thrombin‐antithrombin complexes (TAT), fibrin formation/breakdown (D‐dimer), and thrombin generation potential. No significant differences in TF + EVs, TATs, D‐dimer, or thrombin generation parameters were detected between WS‐ or filtered air‐exposed individuals. Although females had significantly higher TATs and D‐dimers, and slightly but non‐significantly shorter thrombin generation lag times than males, there were no significant differences between WS‐ or air‐exposed males or females in any measurements. These data suggest that acute WS exposure does not increase prothrombotic biomarkers in plasma.
- Open Access
- 29 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
β-hydroxybutyrate suppresses pathological changes of blood-induced arthropathy in rats
Arthropathy is a common complication in haemophilia and decreases quality of life. It has been known that concentrations of β-hydroxybutyrate (BHB) in blood are increased by a ketogenic diet, and elevated levels of circulating BHB restricts the progression of inflammation-mediated joint pathological changes. We hypothesized that elevation of blood BHB concentrations could be effective for reducing the progression of bleeding-induced arthropathy by moderating the inflammatory responses of macrophages. In this study, we investigated whether BHB alleviates the arthropathy caused by repeated intra-articular blood injection in rats. To increase blood BHB levels, rats were fed with ketogenic diet. Repeated intra-articular blood injection induced significant joint swelling, whereas ketogenic diet intake significantly increased blood BHB concentrations and ameliorated the joint swelling. The periarticular tissue-fibrosis observed in the control diet intake group appeared to be significantly alleviated in the ketogenic diet intake group. In addition, the IL-1β, which is involved in the progression of arthropathy, levels in the supernatants of blood-exposed macrophages derived from THP-1 cell line were significantly suppressed by BHB supplementation. In summary, BHB moderated the pathological joint changes caused by intra-articular blood exposure.
- 29 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open Accessβ-hydroxybutyrate suppresses pathological changes of blood-induced arthropathy in rats
Arthropathy is a common complication in haemophilia and decreases quality of life. It has been known that concentrations of β-hydroxybutyrate (BHB) in blood are increased by a ketogenic diet, and elevated levels of circulating BHB restricts the progression of inflammation-mediated joint pathological changes. We hypothesized that elevation of blood BHB concentrations could be effective for reducing the progression of bleeding-induced arthropathy by moderating the inflammatory responses of macrophages. In this study, we investigated whether BHB alleviates the arthropathy caused by repeated intra-articular blood injection in rats. To increase blood BHB levels, rats were fed with ketogenic diet. Repeated intra-articular blood injection induced significant joint swelling, whereas ketogenic diet intake significantly increased blood BHB concentrations and ameliorated the joint swelling. The periarticular tissue-fibrosis observed in the control diet intake group appeared to be significantly alleviated in the ketogenic diet intake group. In addition, the IL-1β, which is involved in the progression of arthropathy, levels in the supernatants of blood-exposed macrophages derived from THP-1 cell line were significantly suppressed by BHB supplementation. In summary, BHB moderated the pathological joint changes caused by intra-articular blood exposure.
- Open Access
- 18 October 2024
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 32 (4) , 101355
Efficient generation of liver sinusoidal endothelial-like cells secreting coagulation factor VIII from human induced pluripotent stem cells
- 18 October 2024
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 32 (4) , 101355
Open AccessEfficient generation of liver sinusoidal endothelial-like cells secreting coagulation factor VIII from human induced pluripotent stem cells
- Open Access
- 29 August 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 26, 654-662
MEK inhibitor PD0325901 upregulates CD34 expression in endothelial cells via inhibition of ERK phosphorylation
- 29 August 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 26, 654-662
Open AccessMEK inhibitor PD0325901 upregulates CD34 expression in endothelial cells via inhibition of ERK phosphorylation
- Open Access
- 20 March 2024
- Published by Wiley in Haemophilia
- Vol. 30 (3) , 780-790
Force‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy
Background: Joint damage in patients with haemophilia (PwH) is commonly assessed by imaging, but few reports have described how structural changes in joints, for example, haemophilic arthropathy (HA)—affect gait ability.Objectives: We evaluated gait function among PwH with HA, PwH without HA, and people without haemophilia (non‐PwH) using a Zebris FDM‐T treadmill (FDM‐T), an easy‐to‐use gait assessment instrument with a force sensor matrix.Methods: The following gait parameters were collected: centre of pressure trajectory intersection (COPi) anterior/posterior variability, COPi lateral variability, COPi anterior/posterior symmetry, COPi lateral symmetry, single‐limb support line (SLSL) length, and SLSL variability. Participants walked at their typical gait speed. The physical function of the PwH was assessed by the Hemophilia Joint Health Score (HJHS). Parameters were compared among the three groups.Results: Twelve PwH with HA, 28 PwH without HA, and 12 non‐PwH were enrolled. Gait speed significantly differed between groups (non‐PwH, 3.1 ± 0.7; PwH without HA, 2.0 ± 0.7; PwH with HA; 1.5 ± 0.4). The COPi anterior/posterior variability, COPi lateral variability, SLSL length, and SLSL variability were greater in the PwH groups than in the non‐PwH group. The COPi lateral symmetry differed between PwH with HA and the other groups. The HJHS was not correlated with gait parameters among PwH with HA.Conclusions: Gait parameters and speed were abnormal in both PwH with HA and PwH without HA. The FDM‐T can be used to identify early stages of physical dysfunction that cannot be detected by conventional functional assessments such as the HJHS.
- 20 March 2024
- Published by Wiley in Haemophilia
- Vol. 30 (3) , 780-790
Open AccessForce‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy
Background: Joint damage in patients with haemophilia (PwH) is commonly assessed by imaging, but few reports have described how structural changes in joints, for example, haemophilic arthropathy (HA)—affect gait ability.Objectives: We evaluated gait function among PwH with HA, PwH without HA, and people without haemophilia (non‐PwH) using a Zebris FDM‐T treadmill (FDM‐T), an easy‐to‐use gait assessment instrument with a force sensor matrix.Methods: The following gait parameters were collected: centre of pressure trajectory intersection (COPi) anterior/posterior variability, COPi lateral variability, COPi anterior/posterior symmetry, COPi lateral symmetry, single‐limb support line (SLSL) length, and SLSL variability. Participants walked at their typical gait speed. The physical function of the PwH was assessed by the Hemophilia Joint Health Score (HJHS). Parameters were compared among the three groups.Results: Twelve PwH with HA, 28 PwH without HA, and 12 non‐PwH were enrolled. Gait speed significantly differed between groups (non‐PwH, 3.1 ± 0.7; PwH without HA, 2.0 ± 0.7; PwH with HA; 1.5 ± 0.4). The COPi anterior/posterior variability, COPi lateral variability, SLSL length, and SLSL variability were greater in the PwH groups than in the non‐PwH group. The COPi lateral symmetry differed between PwH with HA and the other groups. The HJHS was not correlated with gait parameters among PwH with HA.Conclusions: Gait parameters and speed were abnormal in both PwH with HA and PwH without HA. The FDM‐T can be used to identify early stages of physical dysfunction that cannot be detected by conventional functional assessments such as the HJHS.
- Top Cited Papers
- 29 February 2024
- Published by Springer Nature in International Journal of Hematology
- Vol. 119 (5) , 495-504
The pathogenesis of cancer-associated thrombosis
Patients with cancer have a higher risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), compared to the general population. Cancer-associated thrombosis (CAT) is a thrombotic event that occurs as a complication of cancer or cancer therapy. Major factors determining VTE risk in cancer patients include not only treatment history and patient characteristics, but also cancer type and site. Cancer types can be broadly divided into three groups based on VTE risk: high risk (pancreatic, ovarian, brain, stomach, gynecologic, and hematologic), intermediate risk (colon and lung), and low risk (breast and prostate). This implies that the mechanism of VTE differs between cancer types and that specific VTE pathways may exist for different cancer types. This review summarizes the specific pathways that contribute to VTE in cancer patients, with a particular focus on leukocytosis, neutrophil extracellular traps (NETs), tissue factor (TF), thrombocytosis, podoplanin (PDPN), plasminogen activator inhibitor-1 (PAI-1), the intrinsic coagulation pathway, and von Willebrand factor (VWF).
- 29 February 2024
- Published by Springer Nature in International Journal of Hematology
- Vol. 119 (5) , 495-504
Top Cited PapersThe pathogenesis of cancer-associated thrombosis
Patients with cancer have a higher risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), compared to the general population. Cancer-associated thrombosis (CAT) is a thrombotic event that occurs as a complication of cancer or cancer therapy. Major factors determining VTE risk in cancer patients include not only treatment history and patient characteristics, but also cancer type and site. Cancer types can be broadly divided into three groups based on VTE risk: high risk (pancreatic, ovarian, brain, stomach, gynecologic, and hematologic), intermediate risk (colon and lung), and low risk (breast and prostate). This implies that the mechanism of VTE differs between cancer types and that specific VTE pathways may exist for different cancer types. This review summarizes the specific pathways that contribute to VTE in cancer patients, with a particular focus on leukocytosis, neutrophil extracellular traps (NETs), tissue factor (TF), thrombocytosis, podoplanin (PDPN), plasminogen activator inhibitor-1 (PAI-1), the intrinsic coagulation pathway, and von Willebrand factor (VWF).
- 8 October 2023
- Published by Wiley in Macromolecular Bioscience
- Vol. 24 (2) , e2300307
Terminus‐Selective Covalent Immobilization of Heparin on a Thermoresponsive Surface Using Click Chemistry for Efficient Binding of Basic Fibroblast Growth Factor
Cell therapy using endothelial cells (ECs) has great potential for the treatment of congenital disorders, such as hemophilia A. Cell sheet technology utilizing a thermoresponsive culture dish is a promising approach to efficiently transplant donor cells. In this study, a new method to prepare terminus‐selective heparin‐immobilized thermoresponsive culture surfaces is developed to facilitate the preparation of EC sheets. Alkynes are introduced to the reducing terminus of heparin via reductive amination. Cu‐catalyzed azide‐alkyne cycloaddition (CuAAC) facilitates efficient immobilization of the terminus of heparin on a thermoresponsive surface, resulting in a higher amount of immobilized heparin while preserving its function. Heparin‐immobilized thermoresponsive surfaces prepared using CuAAC exhibit good adhesion to human endothelial colony‐forming cells (ECFCs). In addition, upon further binding to basic fibroblast growth factor (bFGF) on heparin‐immobilized surfaces, increased proliferation of ECFCs on the surface is observed. The confluent ECFC monolayer cultured on bFGF‐bound heparin‐immobilized thermoresponsive surfaces exhibits relatively high fibronectin accumulation and cell number and detaches at 22 °C while maintaining the sheet‐like structure. Because heparin has an affinity for several types of bioactive molecules, the proposed method can be applied to facilitate efficient cultures and sheet formations of various cell types.
- 8 October 2023
- Published by Wiley in Macromolecular Bioscience
- Vol. 24 (2) , e2300307
Terminus‐Selective Covalent Immobilization of Heparin on a Thermoresponsive Surface Using Click Chemistry for Efficient Binding of Basic Fibroblast Growth Factor
Cell therapy using endothelial cells (ECs) has great potential for the treatment of congenital disorders, such as hemophilia A. Cell sheet technology utilizing a thermoresponsive culture dish is a promising approach to efficiently transplant donor cells. In this study, a new method to prepare terminus‐selective heparin‐immobilized thermoresponsive culture surfaces is developed to facilitate the preparation of EC sheets. Alkynes are introduced to the reducing terminus of heparin via reductive amination. Cu‐catalyzed azide‐alkyne cycloaddition (CuAAC) facilitates efficient immobilization of the terminus of heparin on a thermoresponsive surface, resulting in a higher amount of immobilized heparin while preserving its function. Heparin‐immobilized thermoresponsive surfaces prepared using CuAAC exhibit good adhesion to human endothelial colony‐forming cells (ECFCs). In addition, upon further binding to basic fibroblast growth factor (bFGF) on heparin‐immobilized surfaces, increased proliferation of ECFCs on the surface is observed. The confluent ECFC monolayer cultured on bFGF‐bound heparin‐immobilized thermoresponsive surfaces exhibits relatively high fibronectin accumulation and cell number and detaches at 22 °C while maintaining the sheet‐like structure. Because heparin has an affinity for several types of bioactive molecules, the proposed method can be applied to facilitate efficient cultures and sheet formations of various cell types.
- 27 September 2023
- Published by Springer Nature in International Journal of Hematology
- Vol. 118 (6) , 699-710
Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice
The relationship between von Willebrand factor (VWF) and inflammation has attracted considerable attention in recent years. VWF, which is stored in the Weibel–Palade bodies (WPBs) of endothelial cells (ECs), is released from WPBs in response to inflammatory stimuli and is thought to contribute to inflammation by promoting leukocyte extravasation. In this study, lung injury model mice were produced by intratracheal injection with lipopolysaccharides. The severity of lung inflammation was evaluated in mice with different genotypes (wild-type, Vwf−/−, Adamts13−/−) and mice treated with drugs that inhibit VWF function. Lung inflammation was significantly ameliorated in Vwf−/− mice compared with wild-type mice. Furthermore, inflammation was significantly suppressed in wild-type mice treated with anti-VWF A1 antibody or recombinant human ADAMTS13 compared with the untreated control group. The underlying mechanism appears to be an increased VWF/ADAMTS13 ratio at the site of inflammation and the interaction between blood cell components, such as leukocytes and platelets, and the VWF A1 domain, which promotes leukocyte infiltration into the lung. This study suggested that ADAMTS13 protein and other VWF-targeting agents may be a novel therapeutic option for treatment of pulmonary inflammatory diseases.
- 27 September 2023
- Published by Springer Nature in International Journal of Hematology
- Vol. 118 (6) , 699-710
Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice
The relationship between von Willebrand factor (VWF) and inflammation has attracted considerable attention in recent years. VWF, which is stored in the Weibel–Palade bodies (WPBs) of endothelial cells (ECs), is released from WPBs in response to inflammatory stimuli and is thought to contribute to inflammation by promoting leukocyte extravasation. In this study, lung injury model mice were produced by intratracheal injection with lipopolysaccharides. The severity of lung inflammation was evaluated in mice with different genotypes (wild-type, Vwf−/−, Adamts13−/−) and mice treated with drugs that inhibit VWF function. Lung inflammation was significantly ameliorated in Vwf−/− mice compared with wild-type mice. Furthermore, inflammation was significantly suppressed in wild-type mice treated with anti-VWF A1 antibody or recombinant human ADAMTS13 compared with the untreated control group. The underlying mechanism appears to be an increased VWF/ADAMTS13 ratio at the site of inflammation and the interaction between blood cell components, such as leukocytes and platelets, and the VWF A1 domain, which promotes leukocyte infiltration into the lung. This study suggested that ADAMTS13 protein and other VWF-targeting agents may be a novel therapeutic option for treatment of pulmonary inflammatory diseases.
- Open Access
- 1 August 2023
- Published by Elsevier in Regenerative Therapy
- Vol. 24, 274-281
Generation of functional liver sinusoidal endothelial-like cells from human bone marrow-derived mesenchymal stem cells
- 1 August 2023
- Published by Elsevier in Regenerative Therapy
- Vol. 24, 274-281
Open AccessGeneration of functional liver sinusoidal endothelial-like cells from human bone marrow-derived mesenchymal stem cells